Literature DB >> 15010625

Heart to Heart: a computerized decision aid for assessment of coronary heart disease risk and the impact of risk-reduction interventions for primary prevention.

Michael Pignone1, Stacey L Sheridan, Yueh Z Lee, Johnny Kuo, Christopher Phillips, Cynthia Mulrow, Roni Zeiger.   

Abstract

Heart to Heart is a computer-based decision aid for patients and providers that provides personalized, evidence-based information about coronary heart disease (CHD) risk and potential risk-reducing interventions. To develop Heart to Heart, the authors used Framing-ham risk equations and systematic reviews of risk-reducing interventions. The Web version was programmed using PHP: Hypertext Processor, a Web-based programming language, and has separate interfaces for providers and patients. The authors subsequently developed a modified version for personal digital assistants. Heart to Heart uses information about a patient's CHD risk factors (age, gender, total and high-density lipoprotein cholesterol levels, diabetes, smoking, systolic blood pressure, and left ventricular hypertrophy) to calculate risk of total CHD events over 5 or 10 years. Patients and providers can then examine the effect of introducing one or more risk-reducing interventions (aspirin, lipid-lowering drug therapy, antihypertensive medication, or smoking cessation) on the patient's CHD risk. Future research will be directed to determining whether Heart to Heart can improve utilization of effective CHD risk-reducing interventions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15010625     DOI: 10.1111/j.1520-037x.2004.2417.x

Source DB:  PubMed          Journal:  Prev Cardiol        ISSN: 1520-037X


  16 in total

1.  Tech meets bio.

Authors:  Monica Heger
Journal:  Nat Med       Date:  2010-08       Impact factor: 53.440

Review 2.  Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.

Authors:  Lora E Burke; Jun Ma; Kristen M J Azar; Gary G Bennett; Eric D Peterson; Yaguang Zheng; William Riley; Janna Stephens; Svati H Shah; Brian Suffoletto; Tanya N Turan; Bonnie Spring; Julia Steinberger; Charlene C Quinn
Journal:  Circulation       Date:  2015-08-13       Impact factor: 29.690

3.  Effect of adding a values clarification exercise to a decision aid on heart disease prevention: a randomized trial.

Authors:  Stacey L Sheridan; Jennifer M Griffith; Lindy Behrend; Ziya Gizlice; Michael P Pignone
Journal:  Med Decis Making       Date:  2010-05-18       Impact factor: 2.583

Review 4.  Risk scoring for the primary prevention of cardiovascular disease.

Authors:  Kunal N Karmali; Stephen D Persell; Pablo Perel; Donald M Lloyd-Jones; Mark A Berendsen; Mark D Huffman
Journal:  Cochrane Database Syst Rev       Date:  2017-03-14

Review 5.  A systematic review of information in decision aids.

Authors:  Deb Feldman-Stewart; Sarah Brennenstuhl; Kathryn McIssac; Joan Austoker; Agathe Charvet; Paul Hewitson; Karen R Sepucha; Tim Whelan
Journal:  Health Expect       Date:  2007-03       Impact factor: 3.377

6.  Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study.

Authors:  Sophie Hill; Janet Spink; Dominique Cadilhac; Adrian Edwards; Caroline Kaufman; Sophie Rogers; Rebecca Ryan; Andrew Tonkin
Journal:  BMC Public Health       Date:  2010-03-04       Impact factor: 3.295

7.  Individuals' responses to global CHD risk: a focus group study.

Authors:  Stacey L Sheridan; Lindy Behrend; Maihan B Vu; Andrea Meier; Jennifer M Griffith; Michael P Pignone
Journal:  Patient Educ Couns       Date:  2009-03-14

8.  Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the Heart to Health study.

Authors:  Stacey L Sheridan; Lindy B Draeger; Michael P Pignone; Philip D Sloane; Carmen Samuel-Hodge; Eric A Finkelstein; Ziya Gizlice; Maihan B Vu; Daniel P Gitterman; Shrikant I Bangdiwala; Katrina E Donahue; Kelly Evenson; Alice S Ammerman; Thomas C Keyserling
Journal:  Contemp Clin Trials       Date:  2013-08-02       Impact factor: 2.226

9.  A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies.

Authors:  Stacey L Sheridan; Lindy B Draeger; Michael P Pignone; Thomas C Keyserling; Ross J Simpson; Barbara Rimer; Shrikant I Bangdiwala; Jianwen Cai; Ziya Gizlice
Journal:  BMC Health Serv Res       Date:  2011-12-05       Impact factor: 2.655

10.  The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial.

Authors:  Petra Denig; Mathijs Dun; Jan Schuling; Flora M Haaijer-Ruskamp; Jaco Voorham
Journal:  Trials       Date:  2012-11-21       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.